Neurocrine Biosciences (NBIX) Intangibles (2022 - 2025)

Neurocrine Biosciences' Intangibles history runs 4 years deep, the most recent figure standing at $35.7 million for Q3 2025.

• Quarterly Intangibles rose 3.48% year-over-year to $35.7 million in Q3 2025, while the trailing twelve-month figure through Sep 2025 was $35.7 million (up 3.48% YoY) and the FY2024 annual result came in at $36.5 million, up 2.82% from the prior year.
• Intangibles was $35.7 million for Q3 2025 at Neurocrine Biosciences, down from $37.2 million in the prior quarter.
• Across five years, Intangibles topped out at $37.2 million in Q4 2022 and bottomed at $33.5 million in Q2 2024.
• A 4-year average of $35.8 million and a median of $36.0 million in 2025 frame the typical range for Intangibles.
• Annual changes were most pronounced in 2024 — Intangibles dropped 9.21% — and 2025, when it grew 11.04%.
• Neurocrine Biosciences' Intangibles stood at $37.2 million in 2022, then slipped by 4.57% to $35.5 million in 2023, then climbed by 2.82% to $36.5 million in 2024, then fell by 2.19% to $35.7 million in 2025.
• Business Quant data shows NBIX's Intangibles at $35.7 million in Q3 2025, $37.2 million in Q2 2025, and $36.4 million in Q1 2025.